GPT and metabolic dysfunction-associated steatotic liver disease: Interestingly, neither having NAFLD status nor an increase in BMI alone was associated with an ALT elevation, but only patients with NAFLD who had BMI increased were independently associated with an increased risk of having ALT elevation for an adjusted OR of 2.37 (95%CI 1.01–5.54, p = 0.046).